- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Transitional Cell, Carcinoma in Japan
Total 1157 results
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdNot yet recruitingMuscle-invasive Urothelial CarcinomaJapan
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Carcinoma, Transitional CellJapan
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Recruiting
-
BayerCompletedCarcinoma, Transitional CellUnited States, Spain, Hungary, China, Belgium, Korea, Republic of, Taiwan, Australia, Singapore, Canada, Japan, Sweden, Russian Federation, Germany, Italy, Israel, Ireland, France, Austria, Denmark, Portugal, Switzerland, Czechia, Slo... and more
-
Hoffmann-La RocheTerminatedCarcinoma, Transitional CellUnited States, Korea, Republic of, France, United Kingdom, Belgium, Canada, China, Greece, Spain, Turkey, Japan, Czechia, Israel, Italy, Russian Federation, Poland, Switzerland, Australia, Germany, Netherlands, Taiwan, Ukraine, Serbia, Finla...
-
BayerActive, not recruitingUrothelial CarcinomaUnited States, Korea, Republic of, Japan, Germany, Italy, Spain, Austria, France
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
Niigata University Medical & Dental HospitalMerck Sharp & Dohme LLCRecruitingOvarian Squamous Cell CarcinomaJapan
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
National Cancer Center, JapanOno Pharmaceutical Co. Ltd; Fiverings Co., Ltd.Active, not recruitingLocally Advanced Esophageal Squamous Cell CarcinomaJapan
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
Eli Lilly and CompanyCompletedUrothelial CarcinomaSpain, United States, Poland, Romania, Taiwan, Ukraine, Netherlands, Mexico, Japan, France, Germany, Belgium, Greece, Russian Federation, Turkey, Canada, Israel, Italy, United Kingdom, Denmark, Korea, Republic of, Australia, Hungary
-
Hokkaido University HospitalMerck Sharp & Dohme LLCRecruiting
-
Hoffmann-La RocheCompletedUrothelial CarcinomaSpain, United States, Korea, Republic of, Canada, United Kingdom, Czechia, Australia, Belgium, Brazil, China, Estonia, Finland, Greece, Hong Kong, Italy, Poland, Portugal, Slovenia, Mexico, Georgia, Russian Federation, Singapore, Th... and more
-
Keio UniversityRecruitingEsophageal Squamous Cell CarcinomaJapan
-
National Cancer Center, JapanRecruitingEsophageal Squamous Cell CarcinomaJapan
-
Yamagata UniversityUnknownMetastatic Renal Cell CarcinomaJapan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Mucinous... and other conditionsUnited States, Korea, Republic of, Japan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
Southern Tohoku BNCT Research CenterActive, not recruitingHead and Neck Cancer | Squamous Cell CarcinomaJapan
-
Telix International Pty LtdCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaJapan
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckJapan
-
Bristol-Myers SquibbCompletedKidney Cancer | Renal Cell CarcinomaJapan
-
BayerCompleted
-
Eisai Co., Ltd.Completed
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaboratorsUnknownNon-small- Cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Tomoshi TsuchiyaCompleted
-
Hamamatsu UniversityCompletedNon-small Cell Lung CancerJapan
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Chugai PharmaceuticalCompleted
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan